Abstract
Flow cytometry is a powerful diagnostic tool most commonly used for immunophenotyping of hematopoietic neoplasms and primary/secondary immunodeficiencies. Other applications include cell sorting, detection of chromosomal abnormalities based on in situ hybridization or polymerase chain reaction, and evaluation of various cellular functions such as proliferation, apoptosis, calcium efflux, and phosphorylation. Flow cytometry measures physical and antigenic properties of particles including cells, chromosomes, and individual molecules. Owing to the availability of numerous antibodies and ever expanding array of fluorochromes, flow cytometry is capable of simultaneous evaluation of multiple parameters. In hematolymphoid malignancies, flow cytometry can be used at the time of the initial diagnosis and for follow-up and prognostication. The diagnosis is based on aberrant immunophenotypes and maturation patterns, different from those typically seen in normal hematopoietic populations. This chapter focuses on the diagnostic applications of flow cytometry and presents a current approach to sample preparation, selection of antibody panels, and essential aspects of analysis and interpretation. In addition, a complete review of immunophenotypic features of major entities of 2008 World Health Organization classification of hematolymphoid neoplasms is discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Reading
Adriaansen H, Boekhorst PAW, Hagemeijer AM, et al. Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression. Blood. 1993;81:3043–51.
Andrieu V, Radford-Weiss I, Troussard X, et al. Molecular detection of t(8;21)/AML1-ETO in AML M1/M2: correlation with cytogenetics, morphology and immunophenotype. Br J Haematol. 1996;92:855–65.
Beck RC, Stahl S, O’Keefe CL, et al. Detection of mature T cell leukemias by flow cytometry using anti T cell receptor V beta antibodies. Am J Clin Pathol. 2003;120:785–94.
Borowitz MJ, Rubnitz J, Nash M, et al. Surface antigen phenotype can predict TEL-AML1 rearrangement in childhood B-precursor ALL: a Pediatric Oncology Group study. Leukemia. 1998;12:1764–70.
Borowitz MJ, Craig FE, Digiuseppe JA, et al. Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry. Cytometry B Clin Cytom. 2010;78:211–30.
Chen I-M, Chakerian A, Combs D, et al. Post-PCR multiplex fluorescent ligation detection assay and flow cytometry for rapid detection of gene-specific translocations in leukemia. Am J Clin Pathol. 2004;122:783–93.
Chen W, Kesler MV, Karandikar NJ, et al. Flow cytometric features of angioimmunoblastic T cell lymphoma. Cytometry Part B (Clin Cyto). 2006;70B:142–8.
Ciudad J, Orfao A, Vidriales B, et al. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection. Haematologica. 1998;83:1069–75.
Domingo-Claros A, Larriba I, Rozmann M, et al. Acute erythroid neoplastic proliferations. A biological study based on 62 patients. Haematologica. 2002;87:148–53.
Edwards BS, Oprea T, Prossnitz ER, et al. Flow cytometry for high-throughput, high-content screening. Curr Opin Chem Biol. 2004;8:392–8.
Gorczyca W. Differential diagnosis of T cell lymphoproliferative disorders by flow cytometry multicolor immunophenotyping. Correlation with Morphology. Methods Cell Biol. 2004;75:595–621.
Harbott J, Mancini M, Verellen-Dumoulin C, et al. Hematological malignancies with a deletion of 11q23: cytogenetic and clinical aspects. Leukemia. 1998;12:823–7.
Helleberg C, Knudsen H, Hansen PB, et al. CD34+ megakaryoblastic leukaemic cells are CD38−, but CD61+ and glycophorin A+: improved criteria for diagnosis of AML-M7? Leukemia. 1997;11:830–4.
Human cell differentiation molecules. http://www.hcdm.org.
Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975;256:495–7.
Kohno T, Yamada Y, Akamatsu N, et al. Possible origin of adult T cell leukemia/lymphoma cells from human T lymphotropic virus type-1-infected regulatory T cells. Cancer Sci. 2005;96:527–33.
Krasinskas AM, Wasik MA, Kamoun M, et al. The usefulness of CD64, other monocyte-associated antigens, and CD45 gating in the subclassification of acute myeloid leukemias with monocytic differentiation. Am J Clin Pathol. 1998;110:797–805.
Kussick SJ, Wood BL. Four-color flow cytometry identifies virtually all cytogenetically abnormal bone marrow samples in the workup of non-CML myeloproliferative disorders. Am J Clin Pathol. 2003;120:854–65.
Li S, Eshleman JR, Borowitz MJ. Lack of surface immunoglobulin light chain expression by flow cytometric immunophenotyping can help diagnose peripheral B cell lymphoma. Am J Clin Pathol. 2002;118:229–34.
Lo Coco F, Avvisati G, Diverio D, et al. Rearrangements of the RAR-alpha gene in acute promyelocytic leukaemia: correlations with morphology and immunophenotype. Br J Haematol. 1991;78:494–9.
Loken MR, Shah VO, Dattilio KL, et al. Flow cytometric analysis of human bone marrow: I. normal erythroid development. Blood. 1987;69:255–63.
Macedo A, Orfao A, Ciudad J, et al. Phenotypic analysis of CD34 subpopulations in normal human bone marrow and its application for the detection of minimal residual disease. Leukemia. 1995;9:1896–901.
Matreo G, Castellanos M, Rasillo A, et al. Genetic abnormalities and patterns of antigenic expression in multiple myeloma. Clin Cancer Res. 2005;11:3661–7.
Ogata K, Nakamura K, Yokose N, et al. Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome. Blood. 2002;100:3887–96.
Perfetto SP, Chattopadhyay PK, Roederer M. Seventeen-colour flow cytometry: unraveling the immune system. Nat Rev Immunol. 2004;4:648–55.
Petrella T, Bagot M, Willemze R, et al. Blastic NK cell lymphomas (Agranular CD4 + CD56 + hematodermic neoplasms). Am J Clin Pathol. 2005;123:662–75.
San Miguel JF, Vidriales MB, Ocio E, et al. Immunophenotypic analysis of Waldenstrom’s macroglobulinemia. Semin Oncol. 2003;2:187–95.
Stelzer GT, Shults KE, Loken MR. CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann N Y Aca Sci.. 1993;677:265–81.
Stetler-Stevenson M, Arthur DC, Jabbour N, et al. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood. 2001;98:979–87.
Stewart CC, Behm FG, Carey JL, et al. U.S.-Canadian consensus recommendations on immunophenotypic analysis of hematologic neoplasia by flow cytometry: selection of antibody combinations. Cytometry. 1997;30:231–5.
Swerdlow SH, Campo E, Harris NL, et al., editors. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008.
Tabernero MD, Bortoluci AM, Alaejos I, et al. Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expression. Leukemia. 2001;15:406–14.
Terstappen LWMM, Safford M, Loken MR. Flow cytometric analysis of human bone marrow III. Neutrophil maturation. Leukemia. 1990;4:657–63.
Terstappen LWMM, Huang S, Picker LJ. Flow cytometric assessment of human T cell differentiation in thymus and bone marrow. Blood. 1992;79:666–77.
van Lochem EG, van der Velden VHJ, Wind HK, et al. Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow. Reference patterns for age-related changes and disease-induced shifts. Cytometry. 2004;60B:1–13.
Wells DA, Benesch M, Loken MR, et al. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood. 2003;102:394–403.
Wood BL, Arroz M, Barnett D, et al. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia. Cytometry B Clin Cytom. 2007;72(Suppl 1):S14–22.
Wu JM, Borowitz MJ, Weir EG. The usefulness of CD71 expression by flow cytometry for differentiating indolent from aggressive CD10+ B cell lymphomas. Am J Clin Pathol. 2006;126:1–8.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this entry
Cite this entry
Czader, M. (2013). Clinical Flow Cytometry in Molecular Genetic Pathology. In: Cheng, L., Zhang, D., Eble, J. (eds) Molecular Genetic Pathology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4800-6_10
Download citation
DOI: https://doi.org/10.1007/978-1-4614-4800-6_10
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-4799-3
Online ISBN: 978-1-4614-4800-6
eBook Packages: MedicineReference Module Medicine